Approval of cheap version of HIV-prevention shot raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV
Covered by 2 sources from 2 countries. First reported by ABC News ·
How 2 newspapers cover this story
Approval of cheap version of HIV-prevention shot raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV
US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
The Lenacapavir injection will cost just $40 a year in 120 countries, in what is seen as a major step towards ending Aids
Coverage details
2 outlets from 2 countries are covering this story: ABC News and The Independent. ABC News published it first, on November 2, 2026; the last outlet to join was The Independent, 2 hours later.
Key names in the coverage: HIV, Drug Administration, Aids and Lenacapavir.
By country: United States (1), United Kingdom (1).
